TWD 51.5
(-2.83%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 726.88 Million TWD | 1916.72% |
2022 | -40.01 Million TWD | 83.85% |
2021 | -247.67 Million TWD | 12.21% |
2020 | -282.1 Million TWD | -58.72% |
2019 | -177.73 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 102.37 Million TWD | -12.57% |
2024 Q1 | 117.09 Million TWD | 34.85% |
2023 Q1 | 246.85 Million TWD | 267.06% |
2023 FY | 726.88 Million TWD | 1916.72% |
2023 Q4 | 86.82 Million TWD | -40.54% |
2023 Q3 | 146.02 Million TWD | -40.92% |
2023 Q2 | 247.18 Million TWD | 0.13% |
2022 FY | -40.01 Million TWD | 83.85% |
2022 Q4 | 67.25 Million TWD | 0.0% |
2021 FY | -247.67 Million TWD | 12.21% |
2020 FY | -282.1 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | -646.198% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | -483.277% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 601.931% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 35.589% |
Synmosa Biopharma Corporation | 594.83 Million TWD | -22.2% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | -404.982% |
Center Laboratories, Inc. | -995.42 Million TWD | 173.023% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | -3999.289% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | -3161.333% |
InnoPharmax Inc. | -70.83 Million TWD | 1126.226% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | -812.028% |
Excelsior Biopharma Inc. | -91.01 Million TWD | 898.679% |
DV Biomed Co., Ltd. | 162.91 Million TWD | -346.189% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 170.142% |
UniPharma Co., Ltd. | -21.81 Million TWD | 3432.352% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | -3225.035% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | -89.978% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | -357.867% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | 1758.951% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | 6388.485% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | -1072.605% |